Frank Worden, MD

home / authors / frank-worden-md

Articles

Treating BRAF V600 and NTRK Gene Fusion Positivity

Lori J. Wirth, MD, Massachusetts General Hospital;Jennifer Sipos, MD, Ohio State University;Frank Worden, MD

February 11th 2021

$The Future of RAI-Refractory DTC Management$

The Future of RAI-Refractory DTC Management

Lori J. Wirth, MD, Massachusetts General Hospital;Jennifer Sipos, MD, Ohio State University;Frank Worden, MD

February 11th 2021

Rationale for Sequencing in Second Line

Lori J. Wirth, MD, Massachusetts General Hospital;Jennifer Sipos, MD, Ohio State University;Frank Worden, MD

February 4th 2021

LIBRETTO-001 Phase 1/2 Trial Overview

Lori J. Wirth, MD, Massachusetts General Hospital;Jennifer Sipos, MD, Ohio State University;Frank Worden, MD

February 4th 2021

$Advice for Managing RAI-Refractory DTC$

Advice for Managing RAI-Refractory DTC

Lori J. Wirth, MD, Massachusetts General Hospital;Jennifer Sipos, MD, Ohio State University;Frank Worden, MD

January 28th 2021

Molecular Testing in Treatment Selection

Lori J. Wirth, MD, Massachusetts General Hospital;Jennifer Sipos, MD, Ohio State University;Frank Worden, MD

January 28th 2021

Sorafenib and Lenvatinib Side Effect Profile and Dosing

Lori J. Wirth, MD, Massachusetts General Hospital;Jennifer Sipos, MD, Ohio State University;Frank Worden, MD

January 21st 2021

$RAI-Refractory DTC Trials: Phase 3 DECISION and SELECT$

RAI-Refractory DTC Trials: Phase 3 DECISION and SELECT

Lori J. Wirth, MD, Massachusetts General Hospital;Jennifer Sipos, MD, Ohio State University;Frank Worden, MD

January 21st 2021

Multidisciplinary Management for the Treatment of DTC

Lori J. Wirth, MD, Massachusetts General Hospital;Jennifer Sipos, MD, Ohio State University;Frank Worden, MD

January 18th 2021

Approaching Treatment of Low-Volume DTC

Lori J. Wirth, MD, Massachusetts General Hospital;Jennifer Sipos, MD, Ohio State University;Frank Worden, MD

January 18th 2021

Understanding Sequencing and What to Look for in DTC

Lori J. Wirth, MD, Massachusetts General Hospital;Jennifer Sipos, MD, Ohio State University;Frank Worden, MD

January 18th 2021

Roles and Communication in Treatment in DTC

Lori J. Wirth, MD, Massachusetts General Hospital;Jennifer Sipos, MD, Ohio State University;Frank Worden, MD

January 11th 2021

Management of DTC in Clinical Practice

Lori J. Wirth, MD, Massachusetts General Hospital;Jennifer Sipos, MD, Ohio State University;Frank Worden, MD

January 11th 2021

$Discussing Iodine-Refractory DTC With Patients$

Discussing Iodine-Refractory DTC With Patients

Lori J. Wirth, MD, Massachusetts General Hospital;Jennifer Sipos, MD, Ohio State University;Frank Worden, MD

January 4th 2021

$Clinical Scenarios to Consider for RAI-Refractory DTC$

Clinical Scenarios to Consider for RAI-Refractory DTC

Lori J. Wirth, MD, Massachusetts General Hospital;Jennifer Sipos, MD, Ohio State University;Frank Worden, MD

January 4th 2021

Thyrotropin Suppression as DTC Treatment Option

Lori J. Wirth, MD, Massachusetts General Hospital;Jennifer Sipos, MD, Ohio State University;Frank Worden, MD

December 21st 2020

Role of Radioiodine Treatment in DTC

Lori J. Wirth, MD, Massachusetts General Hospital;Jennifer Sipos, MD, Ohio State University;Frank Worden, MD

December 21st 2020

DTC: Histological Subtypes and Tumor Differentiation

Lori J. Wirth, MD, Massachusetts General Hospital;Jennifer Sipos, MD, Ohio State University;Frank Worden, MD

December 14th 2020

Differentiated Thyroid Cancer: Increasing Incidence

Lori J. Wirth, MD, Massachusetts General Hospital;Jennifer Sipos, MD, Ohio State University;Frank Worden, MD

December 14th 2020

Dr Pal Previews ASCO 2024 Data in Renal Cell Carcinoma

Prospective Data Reveal Most Young Survivors of Breast Cancer Could Successfully Give Birth

HPV Vaccinations Associated With Lower Rates of HPV-Caused Cancers in Patients Under 40 Years of Age

AI Virtual Navigation May Reengage Patients to Undergo Missed Colonoscopies

View More Latest Conference Coverage

Do Not Sell My Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512